Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. SomnoMed (ASX:SOM) is taking large strides across Europe laying foundations for growth in volume and sales of its ...

SomnoMed subsidiary SomnoMed Canada has acquired the business of Strong Dental, based in Leamington, Ontario. All assets of Strong Dental, an exclusive license to all patents linked to devices made by ...

PLANO, Texas--(BUSINESS WIRE)--SomnoMed Limited (ASX: SOM), the global leader in oral appliance therapy for obstructive sleep apnea (OSA), today announced a significant investment in its managed care ...

FRISCO, Texas--(BUSINESS WIRE)--SomnoMed (ASX:SOM) announced this week that it has received Medicare approval for its new SomnoDent® Herbst Advance Classic and Flex oral devices. The devices, which ...

The global anti-snoring devices and snoring surgery market size is expected to reach USD 2.65 billion by 2030. The market is anticipated to register a significant CAGR of 7.2% over the forecast period ...

Dublin, Aug. 12, 2021 (GLOBE NEWSWIRE) -- The "Sleep Apnea Devices Market, Global Forecast, Impact of COVID-19, Industry Trends by Device Type, Opportunity Company Overview, and Revenue" report has ...

SomnoMed, a global leader in Continuous Open Airway Therapy (COAT) for the treatment of obstructive sleep apnea, won FDA clearance to offer its COAT devices with the DentiTrac Micro-Recorders from ...

Oral sleep apnoea device maker Somnomed is in better shape and angling for a bite of its rivals after a turnaround led by its co-CEOs. While Somnomed had a leading global market share, service levels ...

Add articles to your saved list and come back to them any time. After successfully revamping its approach to its key markets in the US and Europe, specialist medical devices company SomnoMed is ...

An announcement from Somnomed Limited ( ($AU:SOM) ) is now available. SomnoMed Limited has notified the market that 346,000 SOMAA options, which ...